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Comparative Genomic Hybridization (CGH) was also performed and they compared the leukemic cell profile to normal DNA in 28 of the 88, detecting TET2 deletion in one of ten studied patients with a mutated TET2 copy. Thus, copy number alterations and deletion of the wild-type TET2 copy in TET2-mutant CMML cases seem uncommon. Conventional routine cytogenetics study was performed, at the moment of diagnosis, from bone marrow samples in a 24-hours culture without mitogens.
FISH analysis was applied using BAC clones from 32K library Eight of the patients studied had deletion of the gene and their diagnosis corresponded to MDS and sAML. 6 An approximation to our study was published 
